Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/1996
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031533A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996WO1996031532A1 Sugar-modified cytostatics
10/10/1996WO1996031530A1 Novel peptides and remedy for bone diseases containing the same as active ingredient
10/10/1996WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/10/1996WO1996031510A1 Pyrazole derivatives and processes for the preparation thereof
10/10/1996WO1996031504A1 Thrombin inhibitors
10/10/1996WO1996031501A1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
10/10/1996WO1996031499A1 Novel heterocyclic compounds
10/10/1996WO1996031498A1 Novel heterocyclic compounds
10/10/1996WO1996031497A1 Novel heterocyclic compounds
10/10/1996WO1996031492A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
10/10/1996WO1996031478A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
10/10/1996WO1996031477A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
10/10/1996WO1996031475A2 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996WO1996031474A1 Novel heterocyclic compounds
10/10/1996WO1996031468A1 Novel heterocyclic compounds
10/10/1996WO1996031461A1 Phenoxyethylamine derivatives having high affinity for the 5-ht1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
10/10/1996WO1996031226A1 Large area submucosal graft constructs and method for making the same
10/10/1996WO1996031225A1 Urinary bladder submucosa derived tissue graft
10/10/1996WO1996031215A1 Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
10/10/1996WO1996031212A1 A method for the treatment of macular degeneration
10/10/1996WO1996022990A3 Aza and aza (n-oxy) analogs of glycine/nmda receptor antagonists
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996016175A3 Lgmd gene coding for a calcium dependent protease
10/10/1996CA2217651A1 Substituted pyridine derivatives, their preparation and their use as modulators of acetylcholine receptors
10/10/1996CA2217206A1 Novel heterocyclic compounds
10/10/1996CA2217202A1 Novel heterocyclic compounds
10/10/1996CA2217197A1 Novel heterocyclic compounds
10/10/1996CA2217194A1 Novel heterocyclic compounds
10/10/1996CA2217164A1 Sugar-modified cytostatics
10/10/1996CA2217130A1 Novel heterocyclic compounds
10/10/1996CA2216859A1 Thrombin inhibitors
10/10/1996CA2216654A1 Inhibitors of farnesyl-protein transferase
10/10/1996CA2216599A1 Mdp derivatives and conjugates having haematopoietic function stimulating activity, and compositions containing same
10/10/1996CA2216281A1 A method for the treatment of macular degeneration
10/10/1996CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
10/09/1996EP0736532A1 Pyrido(3,2-e)pyrazinones with antiasthmatic activity and process for their preparation
10/09/1996EP0736527A1 Imadazoline derivative, possible tautomer thereof, process of manufacturing therefor, and vulnerary including such derivative or tautomer
10/09/1996EP0736256A1 Enantiomerically-enhanced nutritional energy substrates
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736036A1 Kininogen inhibitors
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0736032A1 Heterocyclic compounds
10/09/1996EP0736022A1 5-(2-imidazolinylamino)benzimidazole derivatives, their preparation and their use as alpha-2 adrenoceptor agonists
10/09/1996EP0736016A1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitor
10/09/1996EP0736008A1 Indole derivatives as anti-estrogens
10/09/1996EP0736007A1 Non-peptide tachykinin receptor antagonists
10/09/1996EP0736006A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors
10/09/1996EP0736004A1 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceuticals
10/09/1996EP0735900A1 Paramagnetic diagnostic formulations and their method of use
10/09/1996EP0735896A1 Parathyroid hormone formulation
10/09/1996EP0735895A1 A method for preventing or controlling cataract
10/09/1996EP0735888A1 Purine compositions and methods for administration
10/09/1996EP0735887A1 $i(IN UTERO) GENE THERAPY FOR FETUSES
10/09/1996EP0735872A1 A method of treating neurogenic inflammation
10/09/1996EP0735870A1 Use of pla 2? inhibitors as treatment for alzheimer's disease
10/09/1996EP0735869A1 A method of treating gastrointestinal motility disorders
10/09/1996EP0735868A1 Use of non-steroidal cyclooxygenase inhibitors to treat elevated intraocular pressure
10/09/1996EP0735863A1 Accelerated release composition containing bromocriptine
10/09/1996EP0735821A1 Methods for the treatment or prevention of conditions associated with amyloidogenic reptides
10/09/1996EP0735819A1 New cryptophycins
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0637236B1 Pharmaceutical preparation and process for its manufacture
10/09/1996EP0513351B1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
10/09/1996CN1133048A Oligopeptides derived from C-reactive protein fragments
10/09/1996CN1133047A Therapeutic peptide derivatives
10/09/1996CN1133043A Bicyclic aromatic compounds as therapeutic agents
10/09/1996CN1133042A Indole derivatives as NMDA antagonists
10/09/1996CN1133040A Benzothiophenes and related compounds as estrogen agonists
10/09/1996CN1133008A Antipsychotic method
10/09/1996CN1133007A Di- and tetra-hydrobenzo|F¨ quinolin-3-ones
10/09/1996CN1133004A Process for conditioning substances
10/09/1996CN1132755A Aescinic lactonic derivative, its prep. and medicine composition thereof
10/09/1996CN1132745A Substituted henzoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
10/09/1996CN1132626A Improved calcium dietary supplement
10/09/1996CN1132625A NK-1 receptor antagonits and 5HT3 receptor antagonists for treatment of emesis
10/09/1996CN1132607A Fortified fruit juices
10/09/1996CN1032951C Tortoise and soft-shelled turtle composition and its prep.
10/08/1996US5563278 Angiotensin II antagonists
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5563164 Treating arthritis, psoriasis, asthma, inflammatory bowel disease, or alzheimer's disease
10/08/1996US5563163 Treatment of degenerative diseases
10/08/1996US5563162 Bradykinin antagonist quinolines
10/08/1996US5563160 N-cyano-N'-pyridylguanidines as serotonin antagonists
10/08/1996US5563151 Platelet activating factor receptor antagonists; antiinflammatory agents, analgesics
10/08/1996US5563144 Antiserotonins, their preparation and pharmaceutical compositions containing them
10/08/1996US5563143 Antiinflammatory agents, autoimmune disorders
10/08/1996US5563141 Heterocyclic compounds
10/08/1996US5563124 Osteogenic product and process
10/08/1996US5563054 Culturing streptomyces in nutrient medium
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5562923 Micronized pharmaceutically inhalable substances
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/07/1996CA2173270A1 Enantiomerically-enhanced nutritional energy substrates
10/03/1996WO1996030762A1 Insulin mimetic and enhancer assay
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
1 ... 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 ... 1564